Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: A retrospective real world study.

被引：1
|
作者：
Chen, Yang
Dai, Guanghai
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.113
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
113
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: A multicenter AGEO study.
    Palle, Juliette
    Tougeron, David
    Pozet, Astrid
    Soularue, Emilie
    Artru, Pascal
    Le Roy, Florence
    Dubreuil, Olivier
    Sarabi, Matthieu
    Williet, Nicolas
    Manfredi, Sylvain
    Martin-Babau, Jerome
    Rebischung, Christine
    Ben Abdelghani, Meher
    Evesque, Ludovic
    Dreanic, Johann
    Hautefeuille, Vincent
    Louvet, Christophe
    Lecomte, Thierry
    Taïeb, Julien
    Zaanan, Aziz
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [2] Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study
    Palle, Juliette
    Tougeron, David
    Pozet, Astrid
    Soularue, Emilie
    Artru, Pascal
    Leroy, Florence
    Dubreuil, Olivier
    Sarabi, Matthieu
    Williet, Nicolas
    Manfredi, Sylvain
    Martin-Babau, Jerome
    Rebischung, Christine
    Ben Abdelghani, Meher
    Evesque, Ludovic
    Dreanic, Johann
    Hautefeuille, Vincent
    Louafi, Samy
    Sefrioui, David
    Savinelli, Francesco
    Mabro, May
    Rousseau, Benoit
    Lecaille, Cedric
    Bouche, Olivier
    Louvet, Christophe
    Lecomte, Thierry
    Bonnetain, Franck
    Taieb, Julien
    Zaanan, Aziz
    ONCOTARGET, 2017, 8 (60) : 101383 - 101393
  • [3] In era of immunotherapy: the value of trastuzumab beyond progression in patients with trastuzumab-resistant HER2-positive advanced or metastatic gastric cancer
    Wang, Hui
    Nie, Caiyun
    Xu, Weifeng
    Li, Jing
    Gou, He
    Lv, Huifang
    Chen, Beibei
    Wang, Jianzheng
    Liu, Yingjun
    He, Yunduan
    Zhao, Jing
    Chen, Xiaobing
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [4] CONTINUATION OF TRASTUZUMAB BEYOND PROGRESSION FOR HER2-POSITIVE ADVANCED GASTRIC CANCER AS SECOND-LINE TREATMENT
    Narita, Yukiya
    Kadowaki, Shigenori
    Taniguchi, Hiroya
    Takahari, Daisuke
    Ura, Takashi
    Andoh, Masashi
    Niwa, Yasumasa
    Hara, Hiroki
    Yamaguchi, Kensei
    Muro, Kei
    ANNALS OF ONCOLOGY, 2014, 25
  • [5] Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience
    T Waddell
    A Kotsori
    A Constantinidou
    N Yousaf
    S Ashley
    M Parton
    M Allen
    N Starling
    P Papadopoulos
    M O'Brien
    I Smith
    S Johnston
    British Journal of Cancer, 2011, 104 : 1675 - 1679
  • [6] Trastuzumab beyond Progression in HER2-Positive Advanced Breast Cancer: The Royal Marsden Experience
    Waddell, T.
    Kotsori, A.
    Constantinidou, A.
    Yousaf, N.
    Ashley, S.
    Parton, M.
    Johnston, S.
    Smith, I.
    CANCER RESEARCH, 2010, 70
  • [7] Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study
    Aziz Zaanan
    Juliette Palle
    Emilie Soularue
    Florence Leroy
    Samy Louafi
    David Tougeron
    Sylvain Manfredi
    Pascal Artru
    Astrid Pozet
    Julien Taieb
    Targeted Oncology, 2018, 13 : 107 - 112
  • [8] Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience
    Waddell, T.
    Kotsori, A.
    Constantinidou, A.
    Yousaf, N.
    Ashley, S.
    Parton, M.
    Allen, M.
    Starling, N.
    Papadopoulos, P.
    O'Brien, M.
    Smith, I.
    Johnston, S.
    BRITISH JOURNAL OF CANCER, 2011, 104 (11) : 1675 - 1679
  • [9] Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study
    Zaanan, Aziz
    Palle, Juliette
    Soularue, Emilie
    Leroy, Florence
    Louafi, Samy
    Tougeron, David
    Manfredi, Sylvain
    Artru, Pascal
    Pozet, Astrid
    Taieb, Julien
    TARGETED ONCOLOGY, 2018, 13 (01) : 107 - 112
  • [10] A Retrospective Comparison of Trastuzumab Plus Cisplatin and Trastuzumab Plus Capecitabine in Elderly HER2-Positive Advanced Gastric Cancer Patients
    Zhu, Bo
    Wu, Jun-Rong
    Zhou, Xiao-Ping
    MEDICINE, 2015, 94 (34) : e1428
12345